Free sample for Tetracaine Hydrochloride - Guanfacine Hydrochloride Guanfacine HCl CAS 29110-48-3 API USP Standard High Purity – Ruifu

Manufacturer with High Purity and Stable Quality Chemical Name: Guanfacine Hydrochloride Synonyms: Guanfacine HCl CAS: 29110-48-3 Guanfacine Hydrochloride is a selective α2A-adrenoceptor agonist. Antihypertensive API High Quality, Commercial Production

Chemical Name	Guanfacine Hydrochloride
Synonyms	Guanfacine HCl
CAS Number	29110-48-3
CAT Number	RF-API40
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C9H10Cl3N3O
Molecular Weight	282.55
Melting Point	211.0~215.0℃
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Off-White Crystalline Powder
Identification	Infrared Absorption; HPLC
Loss on Drying	≤0.50%
Residue on Ignition	≤0.10%
Heavy Metals	≤20ppm
Assay	98.0%~102.0% (HPLC on dried basis)
Chromatographic Purity	≥99.0%
Test Standard	USP Standard
Usage	Active Pharmaceutical Ingredient (API)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation. Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Guanfacine Hydrochloride (CAS: 29110-48-3) with high quality. Guanfacine hydrochloride centrally acting a-adrenoceptor agonist. Antihypertensive. Guanfacine hydrochloride, an anti-hypertensive agent, is a selective α2A-adrenoceptor agonist with Kd of 31 nM and displays 60-fold selectivity over α2B-adrenoceptors. IC50 Value: 31 nM(Kd) Target: Adrenergic Receptor Guanfacine is a sympatholytic. It is a selective α2A receptor agonist. These receptors are concentrated heavily in the prefrontal cortex and the locus coeruleus, with the potential to improve attention resulting from interaction with receptors in the former. Guanfacine lowers both systolic and diastolic blood pressure by activating the central nervous system α2A norepinephrine autoreceptors, which results in reduced peripheral sympathetic outflow and thus a reduction in peripheral sympathetic tone. The therapeutic applications for guanfacine are similar to those of the other centrally acting α2-adrenergic agonists and methyldopa. It has been effective as monotherapy in the treatment of patients with mild to moderate hypertension. One advantage for guanfacine is its once-a-day dosing schedule. The use of diuretics to prevent accumulation of fluid may allow a reduction in the dosage for guanfacine.